S. Hill

Design driven HtL: The discovery and synthesis of new high efficacy β₂-agonists.

G. Pairaudeau, A. Bailey, E. Cadogan, 2011, Bioorganic & medicinal chemistry letters.

Design-driven LO: the discovery of new ultra long acting dibasic β2-adrenoceptor agonists.

G. Pairaudeau, A. Bailey, E. Cadogan, 2011, Bioorganic & medicinal chemistry letters.

Evaluation of a series of bicyclic CXCR2 antagonists.

R. Austin, R. Jewell, M. Christie, 2008, Bioorganic & medicinal chemistry letters.

SAR studies on thiazolo[4,5-d]pyrimidine based CXCR2 antagonists involving a novel tandem displacement reaction.

R. Austin, R. Jewell, M. Christie, 2007, Bioorganic & medicinal chemistry letters.

New non-peptide angiotensin II receptor antagonists. 1: structure - activity relationships of a series of a series of 2(1H)-pyridinones.

A. Tinker, H. Beaton, S. Cooper, 1994 .

Potent blockers of the monocarboxylate transporter MCT1: novel immunomodulatory compounds.

A. Davis, D. Ferguson, L. Kingston, 2006, Bioorganic & medicinal chemistry letters.

Discovery of potent CRTh2 (DP2) receptor antagonists.

S. Teague, R. Weaver, S. Paine, 2006, Bioorganic & medicinal chemistry letters.

Zwitterionic CRTh2 antagonists.

S. Thom, A. Cook, S. Paine, 2011, Journal of medicinal chemistry.